Vitalhub (TSE:VHI – Get Free Report) had its price objective decreased by equities research analysts at Canaccord Genuity Group from C$15.00 to C$14.50 in a research report issued on Monday, BayStreet reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group‘s price objective would suggest a potential upside of 122.39% from the stock’s previous close.
A number of other analysts also recently commented on VHI. ATB Cormark Capital Markets decreased their price objective on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating on the stock in a report on Monday. Scotia lowered their target price on shares of Vitalhub from C$12.00 to C$9.00 and set a “sector outperform” rating on the stock in a research report on Monday. Finally, TD lowered their target price on shares of Vitalhub from C$13.00 to C$9.50 and set a “buy” rating on the stock in a research report on Monday. Nine analysts have rated the stock with a Buy rating. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of C$10.86.
Check Out Our Latest Stock Analysis on Vitalhub
Vitalhub Price Performance
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 earnings per share for the quarter. The business had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. On average, research analysts forecast that Vitalhub will post 0.23 earnings per share for the current year.
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
